Instituto Murciano de Investigación Biosanitaria

What Instituto Murciano de Investigación Biosanitaria does

Instituto Murciano de Investigación Biosanitaria Pascual Parrilla (IMIB) is a public, ISCIII-accredited health research institute headquartered in El Palmar, Murcia, Spain. It unites biomedical researchers from the Servicio Murciano de Salud, Universidad de Murcia, and Universidad Politécnica de Cartagena, operating across seven thematic research areas: hematology/oncology and clinical genetics; cardiovascular and respiratory diseases; digestive and endocrino-metabolic diseases; neurosciences and sensory organs; epidemiology, public health, and health services; immunology, microbiology, and infectious diseases; and biotechnology/bioscience applications. As of Memoria 2023, the institute reported 1,326 total personnel (including 863 researchers), 556 publications with a 6.13 average impact factor, 585 active clinical studies, and 187 active competitive grants.

IMIB's core service and product portfolio comprises the IBiPO international funding office, a Cartera Tecnológica of 28+ patents and utility models (including the granted EIRA epilepsy diagnostic algorithm, MIDENF, and ORACULO trademarks), a Spin-Off Support Program, shared research platforms (bioinformatics, genomics, cell culture, imaging), and a dedicated Innovation Support Unit for technology transfer. Its underlying technology stack includes multi-omics infrastructure, AI-driven analytics in bioinformatics, and clinical research support platforms integrated across regional hospitals.

The institute operates as a non-profit public entity administered and financially managed through the Fundación para la Formación e Investigación Sanitarias (FFIS). Revenue is generated entirely from public-sector sources: 71.30% of 16.7M€ total income (FY2023) derives from public funding (ISCIII competitive grants, FEDER, Horizon Europe, regional government via Comunidad Autónoma de la Región de Murcia), with the remaining 28.70% from industry-linked research services, clinical trial contracts, and technology licensing. The go-to-market model is event- and partnership-driven, focused on scientific seminars, capacity-building sessions, and participation in EU research consortia rather than commercial sales channels.

Name

Instituto Murciano de Investigación Biosanitaria

Legal name

Instituto Murciano de Investigación Biosanitaria Pascual Parrilla

Website

https://imib.es

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

501–1,000 employees

Short description

IMIB is a public, ISCIII-accredited health research institute in Murcia, Spain, uniting researchers from the regional health service and two universities. It operates seven thematic research areas and is funded primarily through competitive public grants and institutional support.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYEDAHAGAI

Biomedical Sciences & Medical Research Institutes (University-Based)

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

SECONDARYHLAGAEAI

Sample Logistics, Biorepository & IVD Kit Management (Trial Support)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

• Biomedical research
• Clinical trials
• Translational medicine
• Public health research
• Health research institute

Headquarters

HQ city

El Palmar

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Competitive Research Funding: Grants and funding from national and international bodies including ISCIII, FECYT, European Commission (FEDER, Horizon Europe)
2. Institutional Support: Base funding from Servicio Murciano de Salud and regional universities
3. Research Services: Platform services for research support including biobanking, genomics, proteomics, and clinical research services

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

IMIB is a publicly accredited biomedical research institute that unites clinicians from the Servicio Murciano de Salud and academic researchers from the Universities of Murcia to conduct translational and clinical research across seven thematic areas (hematology/oncology, cardiovascular/respiratory, digestive/endocrine, neurosciences, public health, immunology/infectious diseases, and biotechnology). It provides shared research platforms, clinical trial coordination, a technology portfolio of patents available for licensing, and an international project office (IBiPO) supporting EU funding applications.

Product overview

IMIB (Instituto Murciano de Investigación Biosanitaria Pascual Parrilla) is a federally-accredited health research institute (Instituto de Investigación Sanitaria Acreditado) uniting researchers from the Servicio Murciano de Salud and universities in the Region of Murcia. The institute operates as a multi-disciplinary research organization with seven thematic research areas spanning hematology/oncology, cardiovascular/respiratory diseases, digestive/metabolic diseases, neurosciences, public health, immunology/infectious diseases, and biotechnology. Its product/service portfolio includes: (1) IBiPO - the International Biohealth Project Office providing support for EU and international funding applications; (2) a Cartera Tecnológica offering patents and utility models for licensing; (3) dedicated innovation support and spin-off development services; (4) shared research platforms providing core facilities; and (5) training and education programs. The institute manages 7 research areas, coordinates clinical studies, and facilitates technology transfer from academic research to clinical and commercial applications.

Differentiator

Problem solved

Functional benefit

Products and services

• IBiPO - International Biohealth Project Office A specialized office supporting researchers in the Region of Murcia with international project development, providing guidance on EU funding programs including Horizon Europe, international collaboration opportunities, and capacity-building sessions.
• Cartera Tecnológica (Technology Portfolio) A searchable catalog of technological offerings, patents, utility models, and intellectual property registrations developed by IMIB researchers, available for licensing or collaboration with industry partners.
• Plataformas de Investigación (Research Platforms) Shared infrastructure and technical platforms providing research support services including bioinformatics, genomics, cell culture, imaging, and other core facilities for institute researchers.
• Formación y Capacitación (Training Programs) Educational programs including courses, seminars, and training activities for researchers, healthcare professionals, and students, supporting professional development in biomedical research.
• Unidad de Apoyo a la Innovación (Innovation Support Unit) Dedicated unit providing guidance on innovation processes, technology transfer, intellectual property management, and collaboration with industry for researchers.
• Spin-Off Support Program Innovation support services including guidance for spin-off creation, technology transfer, and commercialization of research outcomes developed within the institute.
• Clinical Research Support Services Infrastructure and coordination for clinical trials, clinical studies, and research support services conducted across multiple regional healthcare facilities including hospitals in the Servicio Murciano de Salud network.

Quantifiable outcome

• 8.2M€ competitive funding secured in 2023
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Six partnerships are on record, tiered core, major and minor.

• Servicio Murciano de SaludcoreStrategic or Co-development PartnerRegional public health service integrating healthcare professionals into the institute's research activities. Provides clinical settings and patient access for research.
• Universidad de MurciacoreStrategic or Co-development PartnerMain university partner contributing researchers and academic expertise to the institute's research programs.
• Universidad Politécnica de CartagenacoreStrategic or Co-development PartnerTechnical university partner contributing engineering and technology expertise to biomedical research.
• Fundación para la Formación e Investigación Sanitarias (FFIS)coreStrategic or Co-development PartnerFoundation managing research funding, training programs, and administrative support for the institute.
• EU-JAMRAI 2majorStrategic or Co-development PartnerEuropean Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections. IMIB participating in pilot projects for infection prevention and control with regional hospitals including Santa Lucía, Rafael Méndez, Reina Sofía, Los Arcos del Mar Menor, and Vega Lorenzo Guirao.
• REINFORCING NetworkminorStrategic or Co-development PartnerNetwork providing Capacity Building Sessions on citizen engagement in research and innovation projects.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Instituto de Investigación Biomédica de Málaga (IBIMA): Andalusian ISCIII-accredited biomedical research institute. Closest peer in terms of regional-government affiliation and mid-sized institute scale; directly comparable in scientific areas, clinical-trial activity, and EU funding focus.
• INCLIVA - Instituto de Investigación Sanitaria de Valencia: Valencia regional ISCIII-accredited IIS, structurally identical to IMIB: regional government-backed, university-hospital affiliated, multi-area biomedical research with technology transfer function.
• Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM): Madrid ISCIII-accredited IIS anchored at Hospital Gregorio Marañón. Directly comparable in scope, accreditation status, clinical-trial activity, and university-hospital integration model.
• Vall d'Hebron Institut de Recerca (VHIR): Barcelona-based ISCIII-accredited health research institute linked to Hospital Vall d'Hebron. Operates the same accredited-IIS model as IMIB, combining clinical research, translational programs, technology transfer, and EU funding capture.
• IDIS - Instituto de Investigación Sanitaria de Santiago de Compostela: Galicia regional ISCIII-accredited IIS tied to Hospital Clínico Universitario de Santiago. Directly comparable in institute size, regional scope, and translational-research positioning.
• IBSAL - Instituto de Investigación Biomédica de Salamanca: Castilla y León regional ISCIII-accredited IIS attached to Hospital Universitario de Salamanca. Comparable in size, regional scope, multi-area research, and translational focus.
• IIS Aragón - Instituto de Investigación Sanitaria Aragón: Aragon regional ISCIII-accredited IIS linking Hospital Universitario Miguel Servet with Universidad de Zaragoza. Same regional-accreditation model, similar competitive-grant profile.
• Institut d'Investigació Biomèdica de Bellvitge (IDIBELL): ISCIII-accredited biomedical research institute in Barcelona tied to Hospital Universitari de Bellvitge and Universitat de Barcelona. Comparable translational/clinical research mix, patent portfolio, and EU funding profile.
• Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ): Madrid-based ISCIII-accredited IIS linked to Hospital La Paz. Similar multi-area clinical-research structure, similar technology-transfer and patent operations, similar competitive-grant profile.

Broad incumbents

• CIBER - Centro de Investigación Biomédica en Red: ISCIII-funded national thematic research network coordinating multi-area biomedical research programs across Spain. Broader-scope entity that overlaps with IMIB's research areas and is a key collaborator/competitor for the same pool of ISCIII competitive funding.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/imib_rmurcia
• YouTubeyoutube.com/c/IMIBArrixaca
• LinkedInlinkedin.com/company/imib
• Instagraminstagram.com/imib_rmurcia

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto Murciano de Investigación Biosanitaria